Julian Vargas v. Quest Diagnostics Clinical Laboratories, Inc.

CourtDistrict Court, C.D. California
DecidedSeptember 29, 2023
Docket2:19-cv-08108
StatusUnknown

This text of Julian Vargas v. Quest Diagnostics Clinical Laboratories, Inc. (Julian Vargas v. Quest Diagnostics Clinical Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Julian Vargas v. Quest Diagnostics Clinical Laboratories, Inc., (C.D. Cal. 2023).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 CENTRAL DISTRICT OF CALIFORNIA 10 JULIAN VARGAS and AMERICAN ) Case No. CV 19-8108-DMG (MRWx) 11 COUNCIL FOR THE BLIND, individual ) ) 12 and on behalf of themselves and all others ) FINDINGS OF FACT AND ) CONCLUSIONS OF LAW 13 similar situated, ) ) 14 Plaintiffs, ) ) 15 v. ) QUEST DIAGNOSTICS CLINICAL ) 16 ) LABORATORIES, INC., QUEST ) 17 DIAGNOSTICS HOLDINGS, INC., and ) QUEST DIAGNOSTICS ) 18 ) INCORPORATED, ) 19 ) Defendants. ) 20 ) 21 This matter is before the Court following a four-day bench trial that began on 22 November 1, 2022. Jonathan D. Miller, Benjamin J. Sweet, Callum T. Appleby, and Jordan 23 T. Porter appeared on behalf of Plaintiffs Julian Vargas and American Council for the 24 Blind, and the Plaintiff Class. David H. Raizman, Mark S. Sidoti, Betsy Johnson, Daniel 25 S. Weinberger, Michael R. McDonald, and Jan N. Marfori appeared on behalf of 26 Defendants Quest Diagnostics Clinical Laboratories, Inc., Quest Diagnostics Holdings, 27 Inc., and Quest Diagnostics Incorporated (collectively “Quest”). 28 Having carefully reviewed the evidence and the arguments of counsel, as presented 1 at trial and in their written submissions, the Court issues the following findings of fact and 2 conclusions of law pursuant to Rule 52 of the Federal Rules of Civil Procedure. 3

4 I. 5 FINDINGS OF FACT1 6 A. Plaintiffs 7 This is a class action consisting of the following Class Members: 8 All legally blind individuals who visited a Quest patient service center in 9 the United States between January 1, 2018 through December 31, 2019 10 (the “Class Period”) at which the e-check-in self-service kiosk was the 11 primary method for check-in and who, due to their disability, could not use 12 all the functions of the kiosks. 13 Vargas is a legally blind individual who lives in Van Nuys, California. FPTCO ¶¶ 14 5(j), 5(i). American Council of the Blind (“ACB”) is a membership organization that 15 advocates on behalf of the blind and those with visual impairments. Rachfal Trial Decl. ¶¶ 16 6–7. 17 B. Defendants 18 Quest is in the business of providing diagnostic information services, which includes 19 collecting blood and urine specimens from patients that it then tests in accordance with 20 physician orders. Final Pretrial Conference Order (“FPTCO”) ¶ 5(a) [Doc. # 295]. Quest 21 Diagnostics and its subsidiaries receive the specimens for testing from hospitals and 22 medical practices, but also collect specimens for testing through patient service centers 23 (“PSCs”) located throughout the United States. Id. at ¶ 5(b). 24 There is no standard configuration or size for Quest PSCs. Day 1 Tr. at 181:18–19; 25 Reilly Decl. ¶ 8. PSCs are staffed by one or more Patient Service Representatives (“PSRs” 26 27 1 To the extent any of the Court’s findings of fact may be considered conclusions of law or vice 28 versa, they are so deemed. or “phlebotomists”), who are trained to collect blood and other samples from patients, and 1 other staff. Yarrison Decl. ¶ 5. Some PSCs, for instance, have employees whose primary 2 role is to assist patients with check-in. See Reilly Decl. ¶ 8. But Thomas Walsh, Vice 3 President of Strategy and Digital Transformation, testified that generally Quest “does not 4 have a role of a receptionist or attendant within a waiting room . . . . That was not part of 5 the model.” Day 2 Tr. at 28:15–29:10. Instead, the role of assisting patients in the waiting 6 room is usually filled by phlebotomists, who come into the waiting room after finishing 7 with each patient to call the next patient back. Id. at 29:4–22; see also Reilly Decl. ¶ 42, 8 Yarrison Decl. ¶ 5. 9 C. Kiosks 10 In the past, patients at PSCs would indicate their arrival, or check in, by entering 11 their names on a paper sign-in sheet maintained in the waiting room. FPTCO ¶ 6(a). But 12 in 2014 or 2015, Quest began to explore ways to modify PSC check-in practices. FPTCO 13 ¶ 5(d). Quest looked for ways to improve both phlebotomist and customer experience. 14 Day 1 Tr. at 188:12–15. Quest hoped to improve the phlebotomist experience by reducing 15 paperwork and data entry tasks. Carr Decl. ¶ 2; Grant Decl. ¶ 4. Quest also hoped it would 16 reduce wait time for patients. Day 1 Tr. at 121:11–12, 193:2–3. Quest likewise wanted to 17 address privacy concerns patients had raised regarding the paper sign-in sheets, and help 18 reduce patient anxiety and dissatisfaction by informing them where they were in the queue. 19 Day 1 Tr. at 119:20–25, 120:1–3, 121:20–24. In April 2016, Quest chose to install one or 20 more electronic, touchscreen tablets to allow patients to check in at PSCs. FPTCO ¶ 5(e). 21 The tablets, which were Apple iPads, when placed in plastic casings (provided by a 22 corporation called Lilitab) and mounted on posts, were known as “Kiosks.” FPTCO ¶ 5(e). 23 The Kiosks were intended to replace the existing paper sign-in sheets. Day 1 Tr. at 191:3– 24 6. 25 D. Original Kiosk 26 The first Kiosk that was deployed to the PSCs during the 2016–2019 time period 27 (the “Original Kiosk”) contained no tactile markings and had no text-to-speech output. 28 FPTCO ¶ 5(f). Users were prompted to check in by entering a first and last name, birthday, and phone number. Yarrison Decl. ¶ 8. PSC staff endeavored to honor appointment times, 1 regardless of what time the patient checked in, but patients without appointments were 2 placed in a queue to be served. Id. The Kiosk also had a help button, although it was a 3 touchscreen help button that was not useable by blind patients. Day 2 Tr. at 121:5–10. The 4 help button set off a “doorbell” for phlebotomists, although phlebotomists could (and still 5 can) turn it off if they did not like it. Day 1 Tr. at 85:5–10. 6 Quest worked to ensure that the Kiosks satisfied physical design standards for self- 7 service kiosks, including ensuring all operable parts were within “reach range” of a person 8 using a wheelchair and that the Kiosks could be detected by blind individuals using canes. 9 Yarrison Decl. ¶ 9; see also Day 1 Tr. at 165:4–8. Quest was offered versions of the Kiosk 10 that included audio capabilities, and one member of the design team raised the possibility 11 that audio capabilities might help with accessibility for visually impaired patients, but 12 Quest did not select a Kiosk with a headphone jack. Ex. 7; Day 1 Tr. at 61:1–6. The parties 13 agree that the Original Kiosks could not be used by blind patients without phlebotomist 14 assistance. 15 1. Phlebotomist Assistance 16 Yarrison testified that Quest “always knew that people would need help checking in, 17 just like they did with the paper sign-in, and [Quest’s] phlebotomists helped them and 18 assisted them with that.” Day 1 Tr. at 77:14–17. The leaders of the project design team, 19 Christopher Grant and Taylor Carr, testified that Quest expected the reduction in 20 paperwork to increase the amount of time phlebotomists spent with patients, including the 21 amount of time they spent in waiting rooms. Grant Decl. ¶¶ 4–5; Carr Decl. ¶ 2; Day 2 Tr. 22 at 118:20–22; see also Yarrison Decl. ¶ 12. In fact, the Kiosks did reduce transaction time 23 for each patient. See Day 1 Tr. at 193:8–10. The Kiosks were also intended to allow Quest 24 to increase the number of patients it saw each year without hiring more phlebotomists. Day 25 1 Tr. at 127:13–22. Quest says seeing more patients would mean phlebotomists were in 26 the waiting room more frequently, not less frequently. See Carr Decl. ¶ 6; Grant Decl. ¶ 5. 27 28 The project rollout did not call for a reduction in staffing at PSCs. Day 1 Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

PGA Tour, Inc. v. Martin
532 U.S. 661 (Supreme Court, 2001)
Oliver v. Ralphs Grocery Co.
654 F.3d 903 (Ninth Circuit, 2011)
Robin Fortyune v. American Multi-Cinema, Inc.
364 F.3d 1075 (Ninth Circuit, 2004)
Molski v. M.J. Cable, Inc.
481 F.3d 724 (Ninth Circuit, 2007)
Baughman v. Walt Disney World Company
685 F.3d 1131 (Ninth Circuit, 2012)
Skaff v. Meridien North America Beverly Hills, LLC
506 F.3d 832 (Ninth Circuit, 2007)
Kimberly O'Connor v. Scottsdale Healthcare Corporat
582 F. App'x 695 (Ninth Circuit, 2014)
Mark Tauscher v. Phoenix Bd. of Realtors, Inc.
931 F.3d 959 (Ninth Circuit, 2019)
Daniel Lopez v. Catalina Channel Express, Inc.
974 F.3d 1030 (Ninth Circuit, 2020)
O'Connor v. Scottsdale Healthcare Corp.
871 F. Supp. 2d 900 (D. Arizona, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Julian Vargas v. Quest Diagnostics Clinical Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/julian-vargas-v-quest-diagnostics-clinical-laboratories-inc-cacd-2023.